Skorpios Trust - 23 Dec 2024 SCHEDULE 13D/A Report for Stoke Therapeutics, Inc. Common Stock, $0.0001 par value per share (STOK)

Filing Manager
Skorpios Trust
Reporting Manager
Skorpios Trust
Security
Stoke Therapeutics, Inc. Common Stock, $0.0001 par value per share
Symbol
STOK
Shares outstanding
53.1M shares
Disclosed Ownership
6.91M shares
Ownership
13%
Form type
SCHEDULE 13D/A
Filing time
27 Dec 2024, 17:23:14 UTC
Date of event
23 Dec 2024
Next filing
06 Jun 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Blue Horizon Enterprise Ltd. 5.6% 2.97M 0 2.97M /s/ Eleni Constantinon Kyriacou Eleni Constantinon Kyriacou, Director
Ezbon International Limited 7.4% 3.94M 0 3.94M /s/ Eleni Constantinon Kyriacou Eleni Constantinon Kyriacou, Director
Montrago Trustees Limited 13% 6.91M 0 6.91M /s/ Androulla Papadopoulou Androulla Papadopoulou, Director
Skorpios Trust 13% 6.91M 0 6.91M /s/ Androulla Papadopoulou Androulla Papadopoulou, Director 0001869333